A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment.

MLA

Nakagawa, Takayuki, et al. “A Randomized Controlled Clinical Trial of Topical Insulin-like Growth Factor-1 Therapy for Sudden Deafness Refractory to Systemic Corticosteroid Treatment.” BMC Medicine, vol. 12, Nov. 2014, p. 219. EBSCOhost, https://doi.org/10.1186/s12916-014-0219-x.

APA

Nakagawa, T., Kumakawa, K., Usami, S., Hato, N., Tabuchi, K., Takahashi, M., Fujiwara, K., Sasaki, A., Komune, S., Sakamoto, T., Hiraumi, H., Yamamoto, N., Tanaka, S., Tada, H., Yamamoto, M., Yonezawa, A., Ito-Ihara, T., Ikeda, T., Shimizu, A., … Ito, J. (2014). A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment. BMC Medicine, 12, 219. https://doi.org/10.1186/s12916-014-0219-x

Chicago

Nakagawa, Takayuki, Kozo Kumakawa, Shin-ichi Usami, Naohito Hato, Keiji Tabuchi, Mariko Takahashi, Keizo Fujiwara, et al. 2014. “A Randomized Controlled Clinical Trial of Topical Insulin-like Growth Factor-1 Therapy for Sudden Deafness Refractory to Systemic Corticosteroid Treatment.” BMC Medicine 12 (November): 219. doi:10.1186/s12916-014-0219-x.